We previously established that prostate tumors from TRAMP+ mice deficient for Ron signaling also exhibit reduced vascularization which was evident by reduced CD31 positive cell immunohistochemistry as well as a 3-fold decrease in VEGF mRNA [13]. This evidence concerns the gene PECAM1 and prostate neoplasm.